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Active placental transport of maternal serum calcium (Ca2+) to the offspring is pivotal
for proper development of the fetal skeleton as well as various organ systems.
Moreover, extracellular Ca2+ levels impact on distinct processes in mammalian
reproduction. The calcium-sensing receptor (CaSR) translates changes in extracellular
Ca2+-concentrations into cellular reactions. This review summarizes current knowledge
on the expression of CaSR and its putative functions in reproductive organs. CaSR
was detected in placental cells mediating materno-fetal Ca2+-transport such as the
murine intraplacental yolk sac (IPYS) and the human syncytiotrophoblast. As shown in
casr knock-out mice, ablation of CaSR downregulates transplacental Ca2+-transport.
Receptor expression was reported in human and rat ovarian surface epithelial (ROSE)
cells, where CaSR activation stimulates cell proliferation. In follicles of various species
a role of CaSR activation in oocyte maturation was suggested. Based on studies
in avian follicles, the activation of CaSR expressed in granulosa cells may support
the survival of follicles after their selection. CaSR in rat and equine sperms was
functionally linked to sperm motility and sperm capacitation. Implantation involves
complex interactions between the blastocyst and the uterine epithelium. During early
pregnancy, CaSR expression at the implantation site as well as in decidual cells
indicates that CaSR is important for blastocyst implantation and decidualization in
the rat uterus. Localization of CaSR in human extravillous cytotrophoblasts suggests
a role of CaSR in placentation. Overall, evidence for functional involvement of CaSR
in physiologic mammalian reproductive processes exists. Moreover, several studies
reported altered expression of CaSR in cells of reproductive tissues under pathologic
conditions. However, in many tissues we still lack knowledge on physiological ligands
activating CaSR, CaSR-linked G-proteins, activated intracellular signaling pathway, and
functional relevance of CaSR activation. Clearly, more work is required in the future to
decode the complex physiologic and pathophysiologic relationship of CaSR and the
mammalian reproductive system.
Keywords: calcium-sensing receptor, reproduction, testes, ovaries, uterus, placenta
Abbreviations: AC, adenylyl cyclase; cAMP, cyclic adenosine monophosphate; EGFR, epidermal growth factor receptor;
Gd3+, Gadolinium; GV, germinal vesicle; LH, luteinizing hormone; MAPK, mitogen-activated protein kinase; Mg2+,
Magnesium; PI-3K, phosphoinositide 3-kinase; PLC, phospholipase C; PKC, protein kinase C; CaSR, Calcium-
sensing receptor; Ca2+, Calcium; IPYS, Intraplacental yolk sac; ROSE cells, Rat ovarian surface epithelial cells; STB,
Syncytiotrophoblast; PCOS, polycystic ovarian syndrome; PTH, Parathyroid hormone; PTHrP, Parathyroid hormone-related
protein; PY, tyrosine phosphorylation.
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INTRODUCTION
Calcium (Ca2+) is indispensable in the context of mammalian
reproduction (Baczyk et al., 2011; Correia et al., 2015;
Kornbluth and Fissore, 2015). Firstly, Ca2+ contributes to
crucial developmental processes such as skeletal formation and
mineralization (Riccardi et al., 2013; Kovacs, 2014, 2015), lung
(Riccardi et al., 2013) and kidney development (Gilbert et al.,
2011) or formation andmaturation of neuronal circuits and long-
term memory (Leclerc et al., 2011). Therefore, Ca2+ must be
supplied in sufficient quantities to the growing offspring, which is
accomplished by active Ca2+-transport from maternal to fetal or
neonate blood circulation across placental and mammary tissue,
respectively (Olausson et al., 2012; Kovacs, 2014, 2015, 2016).
Secondly, Ca2+ is the most universal second messenger. It is
modulated downstream of numerous receptors and can activate
diverse cytoplasmic signaling proteins (Berridge et al., 2000).
Not surprisingly, therefore, Ca2+ signaling pathways also play
crucial roles in early reproductive events like gamete formation
and maturation in the male and female gonads, and fertilization
as well as pre- and peri-implantation development in the female
reproductive tract (Kashir et al., 2013; Armant, 2015).
Both, extracellular and intracellular Ca2+-linked processes
require a tightly regulated extracellular calcium (Ca2+o )
concentration. Mammals have therefore developed a carefully
balanced Ca2+o homeostatic system, which is based on Ca
2+
o -
sensors. The calcium-sensing receptor (CaSR), is the master
regulator of Ca2+o concentration (Brown, 2013; Tyler Miller,
2013; Alfadda et al., 2014). CaSR controls secretion of a
regulatory hormone, parathyroid hormone (PTH), that in turn
impacts on Ca2+o via cells in the target tissues kidney, intestine,
and bone (Brown, 2013).
CaSR is additionally expressed in other adult tissues,
including the central and peripheral nervous system (Ruat and
Traiffort, 2013; Jones and Smith, 2016), the cardio-vascular
system (Smajilovic et al., 2011; Schepelmann et al., 2016),
the lung (Riccardi et al., 2013), the pancreas (Squires et al.,
2014), the epidermis (Tu and Bikle, 2013), or the intestine
(Macleod, 2013). There, the function of CaSR is not related
to control of Ca2+o -homeostasis. Instead, CaSR modulates
functions such as proliferation and differentiation, apoptosis and
chemotaxis, ion channel activity, or hormone secretion, to name
a few.
The outstanding role of Ca2+ in reproduction together with
CaSR expression in reproductive organs implicates a role of CaSR
in reproductive processes. This review first introduces CaSR and
its functional versatility. It then gives a survey on organs and
processes required for reproduction, and summarizes the still
sparse information on expression, localization, and function of
CaSR in gametes, gonads, uterus, and placenta in health and
disease (summarized in Table 1). Finally, it indicates research
demand in these areas. Expression and function of CaSR in
mammary epithelial cells is not addressed in this article as this
has been reviewed recently (Kovacs, 2016). Likewise, the role of
CaSR in proper development of the skeleton (Riccardi et al., 2013;
Kovacs, 2014), the lung (Riccardi et al., 2013; Brennan et al., 2016)
and the brain (Liu et al., 2013) is not considered in this article.
THE CALCIUM SENSING RECEPTOR,
CaSR, AND ITS FUNCTIONAL VERSATILITY
CaSR is a member of the class C of the G protein-coupled
receptors and is present in all vertebrate classes. The fully
glycosylated monomer has a molecular mass of 160 kDa and
consists of a large N-terminal glycosylated extracellular domain,
a seven transmembrane domain and an intracellular C-terminal
domain. The extracellular domain contains a bi-lobed Venus-
flytrap-like domain. The functional receptor is a dimer, where
the Venus-flytrap-like domains of two monomers are linked via
covalent as well as non-covalent interactions. Ca2+-binding in
the cleft between the two lobes of each Venus-flytrap-like domain
causes a rotation of one monomer relative to the other, which
finally allows for G proteins to interact with the cytoplasmic side
of the CaSR (Zhang et al., 2015).
CaSR is, however, promiscuous in ligand binding; it
can be stimulated by other divalent (Mg2+) and tervalent
(Gd3+) inorganic cations, as well as organic polycations (e.g.,
neomycin, spermine). Moreover, it is modulated by various
physiological stimuli including extracellular pH, L-aromatic
amino acids, and ionic strength. Different ligand binding
sites can stabilize distinct conformational changes, which
results in “ligand-biased signaling.” As a consequence, CaSR
was shown to interact with the heterotrimeric G proteins
Gq/11, Gi/o, G12/13, and Gs and is able to target all major
intracellular signaling pathways. CaSR-mediated activation of
Gq/11 results in stimulation of phospholipase C (PLC), Ca
2+
i
mobilization from intracellular stores, and activation of protein
kinase C (PKC) isoforms. CaSR-coupling to Gi/o can inhibit
adenylyl cyclase (AC). On the other hand, it can activate
mitogen-activated protein kinases (MAPK) such as ERK1/2
and JNK. This can lead to transactivation of the epidermal
growth factor receptor (EGFR). Activation of G12/13 modulates
several pathways. This can lead to migration via rho-mediated
actin polymerization and membrane ruﬄing or induce cell
differentiation. It can also target tyrosine kinases, protein
phosphatases, or activate certain AC isoforms. CaSR-coupling
to Gs also activates ACs. Furthermore, CaSR activation can
stimulate PLA, phosphatidylinositol 3-kinase (PI-3K) and PI-
4K. Overall, major consequences of CaSR activation in cells
are Ca2+i mobilization, regulation of intracellular cAMP levels,
activation of various protein kinases as well as activation of
gene transcription factors. CaSR-mediated signaling, however,
depends on the cell-type-specific expression of important
components of the downstream signaling pathways (Conigrave
and Ward, 2013).
An example for the cell-type specific function of CaSR
is the contradictory role in cancer development, where it
acts as either an oncogene (breast, prostate) or as a tumor
suppressor gene (colon, parathyroid) (Brennan et al., 2013;
Peterlik et al., 2013; Tennakoon et al., 2016). CaSR activation can
also have diametrical consequences in normal and tumor cells
as shown for mammary epithelial cells by activating different G-
proteins (Mamillapalli et al., 2008). The multiple consequences
of CaSR activation are illustrated by its variable impact on
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intracellular Ca2+ concentration. CaSR can directly increase
cytosolic Ca2+ through PLC activation to open Ca2+ channels.
Alternatively, CaSR can trigger ERK/phospho-ERK pathways,
thereby increasing transcription factor (e.g., CREB) activity,
which stimulates expression of Ca2+-channels with appropriate
response elements. And finally, CaSR can increase K+-channel
activity, and as a consequence increase membrane potential and
a Ca2+-driving force. Many intracellular signaling pathways, in
turn, are sensitive to cytosolic Ca2+-rises, and as a consequence,
cellular processes such as proliferation or migration can result
from CaSR activation (Tennakoon et al., 2016).
Overall, CaSR has immense functional versatility by activating
different signaling pathways in a ligand- and cell-type specific
way. In the context of reproduction (see below), mainly activation
of MAPK pathways (e.g., ERK1/2, p38, or JNK) has been
investigated so far, probably because MAPK activation is of great
importance in reproduction (Li et al., 2009; Almog and Naor,
2010; Fan et al., 2012; Nunes et al., 2015). However, CaSR can
also induce other pathways such as the PI-3K/AKT pathway
(Bilderback et al., 2002; Liao et al., 2006) in the reproductive
system. Activation of diverse intracellular signaling routes should
be considered in future studies addressing the function of CaSR
in reproduction.
CaSR AND THE MALE REPRODUCTIVE
SYSTEM
Spermatogenesis
The mass production of the male gamets starts with puberty,
when the hypothalamic-pituitary-gonadal axis is established,
and is a continuous, life-long process. Spermatogenesis consists
of three major phases (1) the proliferation of the stem
cells (spermatogonia) resulting in spermatocytes, (2) two
meiotic divisions that give rise to haploid spermatids, and
(3) spermiogenesis, the differentiation into mature sperms (for
details see Kornbluth and Fissore, 2015). Spermatogenesis occurs
in the seminiferous tubulus of the testes and is supported
by testicular non-germ line cells, such as Sertoli and Leydig
cells, which nourish the sperms and/or produce factors required
for proper spermatogenesis. Within the epididymis the sperms
complete maturation. Secretory products of the male accessory
sex glands (e.g., prostate gland) support the functionality of
sperms. Once in the female tract, sperms undergo capacitation to
increase motility (hyperactivation) and prepare for fertilization
of the oocyte. Only capacitated sperms can bind to molecules in
the egg’s zona pellucida, which triggers the acrosome reaction.
Enzymes released from the acrosome, a Golgi-derived sperm
organelle, digest a way through the zona pellucida enabling the
sperm to follow and to finally fertilize the egg (de Kretser, 2012).
Ca2+ is a major determinant of proliferation and differentiation
of spermatogonia, sperm motility, capacitation, and acrosome
reaction (Breitbart, 2002; Yoshida and Yoshida, 2011; Correia
et al., 2015; Kornbluth and Fissore, 2015). In contrast to Ca2+
channels, which are well studied in sperms (Correia et al., 2015),
sparse information is available on the expression and function of
CaSR in sperm or male reproductive tissues (see also Table 1).
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CaSR Expression in Healthy Male
Reproductive Tissue
In rats, CaSR mRNA expression appeared higher in testes
compared to epididymis (Figure 1A). In testis, CaSR protein
was found in Sertoli cells, spermatogonia, spermatocytes,
and spermatids with highest expression level in spermatids
(Figure 1B). Leydig cells and fibroblasts, in contrast, presented
CaSR negative. Mature sperms in the epididymis also expressed
CaSR, predominantly at the head domain. Epithelial epididymal
cells exhibited staining at the apical pole. Since a calcimimetic
drug (AMG 641) caused a moderate, but significant increase
of motility of isolated rat sperms, a role of CaSR in sperm
motility was suggested. A similar stimulatory effect on pig sperms
mobility indicated expression of CaSR also in male gametes of
this species (Mendoza et al., 2012).
In isolated equine sperms, CaSR protein was located
predominantly in the head of the sperm, with lower expression
seen along the tail. Proteins detected with an anti-CaSR
antibody by western blotting had a molecular weight of 100
and 75 kDa (Macías-García et al., 2016), which is smaller
than that of fully glycosylated CaSR transiently expressed in
HEK cells (160 kDa) (Pidasheva et al., 2006). The authors
suggested involvement of CaSR in sperm capacitation as well
as sperm mobility. Capacitation occurs when alterations in the
extracellular milieu induce cAMP and activate PKA. The result
is tyrosine phosphorylation (PY) of various proteins. Among
factors impacting on PY is Ca2+o . In species such as stallion
(González-Fernández et al., 2013), human and mice (Baker et al.,
2004), Ca2+o in the capacitation medium inhibits PY. Ca
2+-
dependent PY inhibition in stallion sperm was reversed in the
presence of a CaSR antagonist (NPS 2143), while a CaSR agonist
(AC-265347) inhibited PY similarly to Ca2+o . The result suggested
that CaSR reduces capacitation in stallion sperm. A modulatory
role of the pH was observed. In addition, NPS 2143 caused a
significant decrease in sperm motility indicating the CaSR is also
involved in the regulation of equine sperm mobility (Macías-
García et al., 2016).
CaSR and Disorders of the Male
Reproductive System
Diabetes, being an increasing problem worldwide1, can
cause testicular damage and male infertility. A recent study
demonstrated up-regulated CaSR in testicular tissues in
streptozotoxin-induced diabetic rats (Kong et al., 2016).
The diabetic rats had significantly lower testes weights and
serum levels of testosterone compared to healthy controls. A
connection between CaSR activation and testicular damage
was found. Specific activation of CaSR by Gd3+ increased,
while specific inhibition of CaSR by the antagonist NPS 2390
reduced testicular damage in the diabetic rats. Increased lipid
peroxidation, decreased anti-oxidative capacity, increased
apoptosis of germ cells, and activation of the mitochondrial
apoptotic pathways were observed in testicular tissue of
diabetic rats and the parameters were further aggravated by the
administration of Gd3+, and attenuated by NPS 2390. CaSR was
1http://www.who.int/mediacentre/factsheets/fs312/en/ (Accessed June 04, 2016).
found to be an activator of different MAPK pathways (ERK, p38,
JNK). It was concluded that CaSR activation had a pro-apoptotic
impact on germ cells in diabetic rats and overall participated in
diabetes-induced testicular damage.
While CaSR expression in normal rat Leydig cells could
not be shown (Mendoza et al., 2012), cultured Rice H-500
rat Leydig cell tumor express the receptor mRNA and protein
(Sanders et al., 2000). H-500 cells are a transplantable model for
humoral hypercalcemia of malignancy. Humoral hypercalcemia
of malignancy is a syndrome seen in various types of cancers
including prostate cancer, but also testicle or breast cancer.
It arises from tumor-derived humoral factors which destroy
normal calcium homeostasis (Chakravarti et al., 2009). Upon
implantation into adult male rats, H-500 cells start proliferation
and cause hypercalcemia by abundant release of the humoral
factor parathyroid hormone-related protein (PTHrP). PTHrP
release, proliferation, and protection of cells from apoptosis,
are stimulated by Ca2+o via CaSR. CaSR-induced proliferation
depends on AKT and MAPK p38, but not on MAPK ERK1/2
(Tfelt-Hansen et al., 2004). CaSR also stimulates transcription
of the PTHrP gene, and release of PTHrP in H-500 cells by
activating PKC as well as various MAPK pathways (ERK1/2, p38,
JNK) (Tfelt-Hansen et al., 2003a). Partly, these effects are caused
by transactivation of EGFR by CaSR (Tfelt-Hansen et al., 2005).
In addition to PTHrP, Ca2+o also up-regulates mRNA of the
oncogene pituitary tumor transforming gene as well as vascular
endothelial growth factor genes in H-500 cells, which leads to
the robust proliferation and angiogenesis at the site of their
implantation (Tfelt-Hansen et al., 2003b). Stimulation of PTHrP
release initiates a vicious circle of hypercalcemia maintained by
CaSR expression in Leydig cell tumors, which suggests CaSR
as a potential therapeutic target for CaSR antagonists. Colloton
and coworkers investigated the ability of cinacalcet, an allosteric
modulator of CaSR, to attenuate hypercalcemia in mice bearing
H-500 cells and indeed demonstrated that cinacalcet effectively
reduced tumor-mediated hypercalcemia (Colloton et al., 2013).
In an immunohistochemical study, comparing human
prostate cancer tissue sections in microarrays, CaSR expression
was confirmed not only in primary prostate cancer tissue,
but also in normal prostate tissue (Figure 1A). No significant
difference in the CaSR expression level between these tissues
was observed. However, a significant higher expression level
of CaSR was found in the metastatic prostate cancer tissues
obtained from bone (Feng et al., 2014). For breast cancer cells
it was demonstrated that the elevated Ca2+-release during
bone remodeling represents a chemoattractant, which promotes
migration of cancer cells to bone via activated CaSR (Saidak
et al., 2009). CaSR mRNA and protein is also detected in the
highly bone metastatic prostate cancer cell lines PC-3 and
C4-2B, while comparatively lower expression of CaSR is found
in non-skeletal metastatic, epithelial-derived prostate cell line
LNCaP cells (Liao et al., 2006). Prostate cancer most commonly
metastasizes to bone, preferring areas of high bone turnover.
As a result of bone remodeling, Ca2+ and growth factors are
released. In PC-3 and C4-2B, but not LNCaP cells elevated
Ca2+o activated CaSR. Activation resulted in stabilization of
cyclin D, promoted PI-3K/AKT/ mTOR signaling, and increased
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FIGURE 1 | The cartoon depicts (A) major components of the human male reproductive system and (B) major steps in spermatogenesis.
Organs/tissues/cells, which were shown to express CaSR are depicted in color. Red color, CaSR expression shown in human ± other mammalian species; blue color,
CaSR expression shown in mammalian species other than human (for details on species and assumed function of CaSR see Text and Table 1).
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metastatic potential (Liao et al., 2006). A few clinical studies
supported the notion that CaSR promotes lethal prostate cancer.
First, the CaSR Q1011E minor allele, which is common in
populations with African ancestry, appeared to be associated
with a less aggressive form of prostate cancer among African-
American men (Schwartz et al., 2010). A second study assessed
genetic variations across CaSR and lethal prostate cancer risk
in Caucasian men. Common genetic variations in CaSR were
found associated with both higher and lower risk for lethal
prostate cancer. The association was stronger in patients with
lower plasma levels of vitamin D (Shui et al., 2013). Third, in a
study that correlated primary tumor CaSR expression with the
risk for lethal prostate cancer, a higher CaSR tumor expression
was associated with an approximately two-fold higher risk for
lethal progression. This risk was independent of Gleason grade
and pathological stage. Higher CaSR expression was significantly
associated with lethal progression among cases with lower tumor
vitamin D receptor expression but not among cases with high
tumor vitamin D receptor expression (Ahearn et al., 2016).
Research Demands
Reports on CaSR expression in human male reproductive system
are currently mainly related to cancer. For more detailed
information on the role of CaSR in tumors, the reader is referred
to other reviews (Singh et al., 2013; Mateo-Lozano et al., 2016;
Tennakoon et al., 2016). The high CaSR expression in Leydig and
prostate cell tumors asks for further evaluation of the prognostic
usability of CaSR. As CaSR promotes bony metastasis of cancer,
this raises the possibility of reducing the risk of such metastases
with CaSR-based therapeutics.
Infertility is among the most serious social problems affecting
advanced nations today. Infertility affects both men and women.
A variety of known factors is associated with male infertility,
but in 30–45%, the cause of the abnormal semen parameters
is not identified (Jungwirth et al., 2012). In this context,
knowledge of all molecules that impact on proper sperm
development is of relevance. If CaSR would be demonstrated
to significantly improve or reduce sperm quantity or quality,
agonists or antagonists of the receptor, respectively, could serve
for treatment. But currently, many open questions remain. The
intracellular signaling pathways associated with the observed
effect of CaSR on (rat, porcine, and equine) sperm motility
and capacitation remain to be investigated. The predominant
physiological ligands responsible for these effects are unknown.
Of interest, Ca2+ concentrations in the uterine fluid vary during
estrous cycle in various species (Casslén and Nilsson, 1984;
Alavi-Shoushtari et al., 2012; Alavi Shoushtari et al., 2014).
Polyamines (spermine, spermidine, and putrescine), which are
type I calcimimetics (Brown, 2010) are secreted by the prostate
gland into semen. Whether polyamines, or other CaSR ligands
in the semen could be sensed by CaSR expressed on sperms
and have effects, is not known. It is unknown, whether CaSR
under physiological conditions impacts on sperm cell apoptosis.
Likewise, CaSR may modulate acrosome reaction or spermatic
hyperactivation. The function of CaSR expressed in (rat) Sertoli
cells and epididymal cells remains to be investigated. CaSR
expression was not observed in healthy rat Leydig cells. However,
there is functional evidence for a divalent cation (Ca2+) receptor
present on the surface of murine cells inducing Ca2+ release from
ryanodine receptor-gated intracellular Ca2+ stores (Adebanjo
et al., 1998). Since a raise of extracellular Ca2+ can induce
testosterone secretion of Leydig cells (Meikle et al., 1991),
re-evaluation of CaSR expression in Leydig cells in mammalian
species might be of interest when looking for new therapies to
increase or reduce hormone secretion. The molecular size of
CaSR protein detected in equine sperm is small compared to
the mature glycosylated CaSR. The reason for this difference is
currently unknown. It may relate to different glycosylation of
CaSR or alternatively spliced CaSR in the tissue. In addition,
a recent study indicated that the western blotting profiles in
tissues depend on the anti-CaSR antibody used (Graca et al.,
2016). Various anti-CaSR antibodies were used in the studies
summarized in this review. They are listed in Table 1.
CaSR IN OVARY AND OOCYTES
Ovaries and Oogenesis
Only a small number of mature oocytes is released during
the reproductive years of a woman. Ovulation occurs in cycles
consisting of follicular phase, ovulation and luteal phase. The
follicular phase is characterized by estrogen dominance, while
in the luteal phase, progesterone is the dominant sex hormone.
Due to the cyclic release of the steroids, the female body exhibits
cyclicity, which is accompanied by structural and functional
changes in the ovaries, oviducts, and the uterus. In most animals,
this is called estrous cycle, while higher primates including
human experience menstrual cycles. The reason of the changes
occurring during female cyclicity is the dual function of the
female reproductive tract. Under estrogen dominance, the body
is prepared to receive the male gametes and enable fertilization,
while under progesterone dominance the body is prepared for
implantation and nourishment of the conceptus (for details see
Findlay, 2012).
The ovarian surface is covered with a single layer of epithelial
cells. Ovarian surface epithelial cells are responsible for the
most malignant forms of ovarian carcinoma. In the ovarian
cortex, ovarian follicles of various sizes and at different stages
of development are located. The follicles are the functional
units of the ovary. They contain a single oocyte and are
surrounded by epithelial granulosa cells. Theca cells are closely
associated with the follicles. Theca cells differentiate from the
interfollicular stroma due to signals from growing follicles and
produce the androgen substrate, which is required for estrogen
biosynthesis in the granulosa cells. After ovulation, theca cells
are transformed from androgen-producing to progesterone-
producing cells, thereby becoming the pregnancy-maintaining
cells of the corpus luteum. The polycystic ovary syndrome
(PCOS) is characterized by hyperandrogenism, oligo- and/or
anovulation, and polycystic ovarian morphology. PCOS is
associated with insulin resistance, hyperinsulinemia and central
obesity. Excessive proliferation of theca cells is often associated
with PCOS; this is a major cause of infertility due to ovarian
hyperandrogenism (Magoffin, 2005).
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Oogenesis starts with the formation of primary oocytes
during the fetal period in utero. Stem cells (oogonia) first
proliferate and then enter the first meiotic division, which is
halted in a prophase state of meiosis I until sexual maturity.
This first meiotic arrest is characterized by a large nucleus
called the germinal vesicle (GV see Figure 2B). The oocyte
and the surrounding granulosa cells, together constituing
the primordial follicles, have complex paracrine interactions
during follicle growth and development. Oocyte maturation
depends on secretory products of the surrounding cells (Findlay,
2012).
Oocyte maturation—defined as the period of progression
from the first to the second meiotic arrest—starts with puberty,
when during the follicular phase of each menstrual/estrous cycle,
a pool of follicles is recruited. Hormonal signals stimulate the
oocytes as well as their surrounding granulosa cells to grow
and theca cells attach to the follicle. One dominant follicle
continues growing. Increasing estrogen levels produced by the
follicle’s granulosa cells cause a pulsatile release of luteinizing
hormone (LH) from the pituitary gland, which stimulates the
release of the oocyte from the ovary (ovulation). Upon that
stimulus, meiosis I continues and is terminated shortly before
ovulation. Oocytes at metaphase I (MI) stage are defined
as oocytes with no GV (intact nucleus) and no polar body
(see Figure 2B). Granulosa cells and the oocyte cooperate and
transmit signals involved in maintaining or releasing the meiotic
arrest in the oocyte. The arrest in prophase I is mediated by
elevated levels of cyclic adenosine monophosphate (cAMP).
Activation of MAPKs triggers degradation of cAMP, allowing
oocyte maturation to proceed. Ca2+ plays a role in controlling
LH-induced as well as spontaneous oocyte maturation, possibly
by modulating intracytoplasmic cAMP concentrations via Ca2+-
sensitive AC (Silvestre et al., 2011, 2012; Chen et al., 2013). By
termination of meiosis I, the diploid primary oocyte generates
two haploid daughter cells. One cell becomes the secondary
oocyte (MII stage of oocyte), while the other cell forms
the first polar body (see Figure 2B). The released oocyte is
surrounded by the zona pellucida, a thick specialized extracellular
matrix as well as additional layers of granulosa cells (corona
radiata).
The ovulated oocyte, which enters the fallopian tube, is now
arrested at metaphase of meiosis II to prevent parthenogenesis
(self-fertilization). For transition of the unfertilized egg to a
developing embryo, egg activation is initiated by alterations
in Ca2+i , which is triggered by fusion of the sperm with the
egg involving a sperm-derived factor. The type of Ca2+-signal
is species dependent, a prolonged series of Ca2+i oscillations
in the egg cytoplasm is characteristic in e.g., mammals, while
other species (e.g., fish) exhibit a single increase in Ca2+i
concentration (Kornbluth and Fissore, 2015). Egg activation
comprises a series of events including cortical granule exocytosis,
modifications of the zona pellucida and plasma membrane
to prevent polyspermy, completion of meiosis II in the egg,
recruitment of maternal mRNAs into polysomes for translation,
and formation of male and female pronuclei (Schultz and
Kopf, 1995; Wang and Machaty, 2013; Swann and Lai,
2016).
CaSR in Ovarian Surface Epithelial Cells
Expression of CaSR in the ovary was first described in human
surface epithelial cells (Figure 2A and Table 1). Proteins detected
by western blotting show a molecular weight of 120–140 kDa
(McNeil et al., 1998). Increasing Ca2+o concentrations induced a
significant proliferative response in these cells, indicating that the
cells can sense Ca2+ concentrations in the surroundings. Induced
proliferation of these cells due to high Ca2+ concentrations
may be of physiological relevance during the healing of the
ruptured surface following each ovulation, when neighboring
cells are locally exposed to ovarian follicular fluid. At least in
pig ovarian follicular fluid, Ca2+ concentrations of around 2.34
mmol/L have been measured (Schuetz and Anisowicz, 1974);
CaSR is active above threshold Ca2+o levels between 0.5 and
2 mmol/L (Conigrave and Ward, 2013). Upon treatment of
human surface epithelial cells with the CaSR agonists Gd3+,
Ca2+ as well as neomycin, intracellular Ca2+ release occurred.
The same observation was made in rat ovarian surface epithelial
(ROSE) cells. There, inositol triphosphate production increased
after stimulation with Gd3+ and Ca2+. Expression of an
interfering mutant CaSR inhibited the proliferative response
to elevated extracellular Ca2+. CaSR agonists induced tyrosine
phosphorylation, ERK activation and proliferation. Expression
of interfering mutants for Ras, Raf, and MKK1 indicated that
proliferation of ROSE cells in response to increased Ca2+o involves
cross-talk between CaSR and a tyrosine kinase-dependent Ras-
Raf-MKK1-ERK signaling pathway. Interestingly, agonists of
CaSR also increased the kinase activity of Src, which is a proto-
oncogene (Hobson et al., 2000). This work was later extended
by Bilderback et al. (2002), who demonstrated an additional
ERK-independent, but PI-3K/AKT-dependent component in the
proliferative response of ROSE cells. Activation of these pathways
has also been observed upon stimulation of CaSR in prostate and
Leydig cell lines (see Section CaSR and Disorders of the Male
Reproductive System)
Ovarian surface epithelial cells are the cell type primarily
responsible for malignant ovarian carcinoma, which is the most
lethal female genital malignancy. McNeil et al. (1998) observed
increased expression of CaSR mRNA in two ovarian tumor cell
lines (BG-1 and CAOV-3). More evidence for a link between
CaSR and ovarian cancer is given by the observation that the G
allele of the CaSR rs17251221 polymorphism seems to protect
against ovarian cancer (Yan et al., 2015). CaSR is considered as
a molecule that can either promote or prevent tumor growth
depending on the type of cancer (Tennakoon et al., 2016). The
exact role of CaSR the development of ovarian cancer remains to
be determined.
CaSR in Follicular Cells
CaSR is present at the surface of human oocytes and granulosa
cells within the corona radiata (Figure 2B andTable 1).Western-
blot analysis revealed a single 130 kDa protein in denuded
oocytes and a protein doublet of 130/120 kDa in cumulus cells
(Dell’Aquila et al., 2006). The expression and localization of CaSR
protein in human oocytes at different maturation stages (GV,
MI, and MII) was studied by immunofluorescence microscopy.
Increased CaSR protein expression in the MI stage as compared
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FIGURE 2 | The cartoon depicts (A) major components of the human female reproductive system and (B) major steps in oogenesis. Organs/tissues/cells,
which were shown to express CaSR are depicted in color. Red color, CaSR expression shown in human ± other mammalian species; blue color, CaSR expression
shown in mammalian species other than human (for details on species and assumed function of CaSR see Text and Table 1).
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to GV and MII oocytes (Figure 2B) suggested a role of CaSR in
the process of meiotic maturation, which would correlate with
the observed role of external Ca2+ in mobilization of intracellular
Ca2+ during oocyte maturation, activation, and fertilization
(review by Tosti, 2006).
CaSRmRNA and protein expression was also shown in equine
follicles (Table 1). Again, western blot analysis revealed a single
130 kDa protein in denuded oocytes and a protein doublet of
130/120 kDa in cumulus cells (De Santis et al., 2009). When
studied by confocal microscopy, CaSR was demonstrated at the
plasma membrane and, more pronounced, within the cytoplasm
of oocytes at all examined stages of meiosis (GV, MI, MII).
Corona radiata cells exhibited strong plasma membrane labeling.
CaSRwas also detected in the transzonal cytoplasmic processes of
corona radiata cells, which penetrate through the zona pellucida
and contact the oocyte membrane. A role of CaSR in oocyte
maturation was investigated. The CaSR agonist NPS R-467,
which is an allosteric modulator of CaSR sensitizing the CaSR
to Ca2+ without activating it, in the absence of Ca2+, had a
stimulatory effect on oocyte maturation. Pre-incubation with the
CaSR antagonist NPS 2390 attenuated the effect. Stimulation
of maturation by CaSR agonist depended on the presence of
external Ca2+(2.92 mM) and was not observed at suboptimal
external Ca2+(0.5 mM). However, variations of Ca2+ between 0.5
and 4 mMCa2+ in the absence of the agonist did not stimulate in
vitro oocytematuration. In oocytes treated withNPS R-467, CaSR
immunostaining increased at the plasma membrane, while it was
reduced in the cytosol. Finally, treatment of oocytes as well as
cumulus cells with CaSR agonist resulted in an increased activity
(phosphorylation) of MAPK (ERK) in these cells (De Santis
et al., 2009). Activation of MAPK is necessary for gonadotropin-
induced meiotic resumption of oocytes (Fan and Sun, 2004).
CaSR mRNA and protein is also present in porcine oocytes
and cumulus cells (Table 1). In contrast to human and equine
oocytes, a 160 kD protein was detected by western blotting.
The effects of gonadotropins and EGF, two key factors involved
in oocytes maturation (Conti et al., 2006; Uhm et al., 2010),
on CaSR expression and localization in porcine oocytes were
tested. CaSR expression was up-regulated in oocytes matured
in gonadotropin-containing, but not EGF-containing medium.
Cortical distribution of CaSR was enhanced with gonadotropins
but not EGF. Porcine cumulus-oocyte-complexes exposed to
CaSR agonist NPS R-568 in gonadotropin-containing medium
showed increased maturation rate, while CaSR antagonist NPS
2390 to medium supplemented with gonadotropins significantly
decreased oocytematuration.MAPK (ERK) phosphorylation was
increased during in vitro maturation as well as after NPS R-
568 treatment. Treatment with NPS 2390 resulted in reduced
levels of phosphorylated MAPK during oocyte maturation. It
was concluded that CaSR participates in gonadotropin-induced
oocyte nuclear maturation through MAPK signal transduction
(Liu et al., 2015).
Apoptosis of granulosa cells is an important process in
follicular atresia. The causal relationship between Ca2+ and
induction of apoptosis was investigated in cultured avian
granulosa cell explants of Japanese quail (Coturnix japonica).
Increasing extracellular Ca2+ resulted in a biphasic response of
the cells; an initial inhibitory effect on apoptosis was followed by
a delayed phase of increased apoptosis. As the initial inhibitory
effect of the Ca2+ on apoptosis was mimicked by applying the
CaSR agonists Mg2+ and Gd3+, an involvement of CaSR in
inhibition of apoptosis was suggested (Mussche et al., 2000). In
a follow up paper, the same group by immunocytochemistry
confirmed expression of CaSR in granulosa cells of quail pre-
ovulatory follicles as well as in the remnants of the granulosa
layer after ovulation (Table 1). CaSR was not detected in the
granulosa cells of smaller undifferentiated follicles. The presence
of CaSR in follicles destined to ovulate was confirmed by western
blotting showing a protein of 115-125 kDa. The rate of apoptosis
of F1 granulosa explants (F1 being the largest preovulatory
follicle) stimulated by either gonadotropin withdrawal alone or
in combination with C8-ceramide was significantly decreased
with a CaSR agonist (NPS R-568) as well as the ions Ca2+ and
Mg2+. The authors suggested that activated CaSR may play a
role in securing the survival of avian follicles after their selection
(Diez-Fraile et al., 2010).
Research Demands
Disturbance in oocyte meiotic events can lead to subfertility or
premature aging by reducing the functional ovarian reserve. Any
molecular target that would allow for promoting or reducing
oocyte maturation would therefore be of interest. Expression of
CaSR in human, equine, and porcine oocyte has been shown. In
analogy to sperms, the molecular weight of the detected CaSR
protein in oocytes and granulosa cells differs between the species.
Reasons for that are given in Section Research Demands (page 7).
Current data support a role of CaSR in maturation (completion
of first meiosis) of oocytes and a contribution of the MAPK ERK
signaling pathway. However, the interplay of CaSR with other
molecules that maintain oocytes in the meiotic arrest and those
that initiate meiotic resumption (such as LH) (Celik et al., 2015)
is currently not well explored.
The oocyte–somatic cells interaction is very important. Low
quality of somatic cells and difficulties in the interaction
between oocyte and granulosa cells can reduce the fertilization
and implantation capacity of the oocyte/zygote, which again
results in poor pregnancy outcome. The expression of CaSR in
granulosa cells of various species was confirmed, but current data
addressing the function of CaSR in these cells are still limited and
point toward an anti-apoptotic function. Expression of CaSR in
theca cells remains unexplored. PCOS is a common multifaceted
metabolic disease in women of fertile age, which has a strong
genetic component. Recent results provided evidence that CaSR
Hin1I gene polymorphism represents a candidate for the genetic
contribution to the development or the severity of insulin
secretion in women with PCOS; So far, the exact molecular
mechanism underlying this association is largely undetermined
(Ranjzad et al., 2011). It remains to be demonstrated whether
theca cells are also affected.
Finally, CaSR expression was observed in epithelial surface
cells of ovaries, where it promotes a proliferative response. Up-
regulation of the response in case of tumors need to be further
explored before therapeutic use of antagonist can be considered.
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CaSR IN THE UTERUS
Uterus and Implantation
During mammalian development, parts of the Müllerian ducts
develop into the female uterus. The extent of duct-fusion is
species-dependent, resulting in different shapes such as simplex
uterus in humans and primates, or duplex uterus in rodents such
as rats and mice. Irrespective of the shape, the function of the
uterus is to enable implantation of the fertilized egg (zygote),
to house the growing conceptus and to expulse the fetus during
delivery (Spencer et al., 2012).
The uterus consists of a tripled-layered wall, composed
of perimetrium, myometrium and endometrium. The
endometrium is a mucosal layer which undergoes marked
changes in thickness and structure during the estrous cycle in
animals such as rats (Westwood, 2008), but most pronounced
changes are seen during the menstrual cycle of humans/primates
(Fazleabas and Strakova, 2002). The early embryo enters the
uterus in the morula state (12–16 cells). Then, transformation
into the blastocyst occurs, which is comprised of a layer of
trophectoderm cells that contacts the uterine epithelium and
starts to form the placenta, and the inner cell mass that gives
rise to the embryo. The blastocyst can implant after shedding
the zona pellucida; in human, implantation occurs 9 days post
coitum (p.c.), while in rats and mice it occurs 4–5 days p.c. The
principle purpose of implantation is to enable a contact between
maternal blood supply and the developing embryonic blood
vessels. The mechanism of implantation of the conceptus is,
however, species dependent. Based on the interaction between
blastocyst and uterine cells it is classified as being interstitial
(e.g., human, guinea pig), centric (e.g., rabbits, domestic
animals), and eccentric (e.g., rats, mice) (Lee and DeMayo,
2004). During interstitial implantation the conceptus breaks
through the surface epithel of the maternal uterus and invades
the underlying stroma. Centric implantation means fusion of
blastocyst with uterine epithelium without penetration and in
eccentric implantation, the luminal epithelium invaginates and
surrounds the blastocyst. Due to implantation, endometrial
stromal cells undergo the decidual reaction and become decidual
cells (Gellersen et al., 2007).
Successful implantation requires a delicate interplay of
many molecules in a limited period of time (the window
of implantation). If communication between the embryo and
the endometrium fails, then implantation fails. This is an
important cause of infertility. There are estimations that
only 50–60% of all conceptions advance beyond 20 weeks
of gestation and from the pregnancies that are lost, 75%
represent a failure of implantation. Failed implantation is
also a major limiting factor in assisted reproduction. To
treat disorders such as infertility, which increases worldwide
due to an increasing toxic environment, but also diseases
such as obesity, it is important to understand the molecular
mechanisms of implantation and placentation (Norwitz et al.,
2001). Many factors including steroid hormones, cytokines, and
growth factors, but also Ca2+i play a role in the course of
implantation (Ruan et al., 2014). Ca2+i seems to promote the
blastocyste-endometrium interaction (Thie and Denker, 2002).
Of interest, the Ca2+o concentration in rat uterine secretion
changes at the time of implantation (Nilsson and Ljung,
1985).
Expression of CaSR in the Uterus
Xiao et al. (2005) found CaSR mRNA expression in rat uterus
(Figure 2A and Table 1). CaSR mRNA and protein appeared
in the luminal epithelium on day 1 of pregnancy. Expression
of CaSR was switched from the luminal epithelium to stromal
cells on days 1–3 of pregnancy. Expression diminished on day
4, but was again induced by the implanting blastocyst. The
results suggested that CaSR expression in the stromal cells in
the receptive status of the uterus was induced by the implanting
blastocysts, while in epithelial cells during day 1 through
day 5, the expression of CaSR was regulated by some non-
embryonic factors. An embryo transplantation model confirmed
that CaSR expression in the uterus was induced by the implanting
blastocysts. Artificial decidualization caused upregulation of
CaSR expression in the decidualized cells. Furthermore, estrogen
as well as progesterone induced the expression of CaSR protein
in the uterus. The strong CaSR expression at the implantation
site and decidual cells in rat uterus suggests that CaSR is of
relevance for blastocyst implantation and decidualization (Xiao
et al., 2005).
In addition to the endometrium, also the myometrium, the
thick muscular coat of the uterus, has important functions
during reproduction as it contributes to sperm and embryo
transport, but also to implantation. Ca2+ plays an important
role for the uterine contractility (Aguilar and Mitchell, 2010).
Based on the observation that uterine contractions can be
inhibited by the CaSR ligands spermine and high concentrations
of Mg2+, it was speculated that CaSR was involved in the
regulation of myometrial contractility (Pistilli et al., 2012).
CaSR expression was confirmed in the estrogen-dominated
rat uterus. Highest expression of CaSR was seen in the
luminal epithelium, but it was also detected in longitudinal
and circular muscle layers of the myometrium (Figure 2A
and Table 1). Oxytocin-induced contraction of the rat uterus
was not only inhibited by various CaSR agonists such as
polyvalent cations and polyamines, but also by two synthetic
positive allosteric CaSR modulators, (R)-calindol and (R)-
cinacalcet. However, the positive allosteric modulation of CaSR
did not show the appropriate stereoselectivity. (S)-cinacalcet,
which is usually less potent than the (R)-enantiomer, inhibited
contraction to the same extent. Furthermore, the negative
allosteric modulator calhex 231 also caused concentration-
dependent relaxation. Thus, the pharmacological profile of
inhibition of contractility by CaSR ligands was not consistent
with their effects being mediated through CaSR, but was
rather consistent with promiscuous actions of the ligands.
Later, the same authors investigated CaSR expression and
function in the pregnant human myometrium. Despite bright
staining in the human placenta, only sparse expression of
CaSR receptors in pregnant human myometrium was observed
(Figure 2A and Table 1). Exposure of human myometrial
strips to CaSR receptor ligands showed that calindol and
Frontiers in Physiology | www.frontiersin.org 11 August 2016 | Volume 7 | Article 371
Ellinger CaSR in Reproduction
cinacalcet, CaSR agonists, were ineffective as inhibitors of
contractions, while the CaSR antagonist calhex 231 produced
partial inhibition of contractility (Crankshaw et al., 2013). In
summary, the role of CaSR in the rat myometrium remains
unclear.
Research Demand
In assisted reproduction, implantation failure is the pregnancy
rate-limiting step. The mechanisms underlying human embryo-
endometrium signaling are not fully understood, but this
is required to improve assisted reproduction outcomes. A
detailed understanding of the implantation process is also
crucial to develop effective interventions to prevent early
pregnancy loss. The small number of studies currently addressing
CaSR expression in the uterus demonstrated expression in
rat endometrium, but more functional studies confirming the
suggested role in implantation and decidualization are required,
not only for the rat system, but also for humans and all
other species, where assisted reproduction could be of interest.
It is known that studies done in animal models do not
always translate well to humans. Human in-vitro models of
implantation (Weimar et al., 2013) may provide an alternative
possibility to study human CaSR function during implantation
and decidualization. Expression of CaSR in the myometrium was
so far only investigated in rat and human. The function of CaSR
in the myometrium remains unclear.
PLACENTA
Placenta Formation and Function
Placentas are unique and transient organs, which develop in
female mammals during pregnancy at the interface of maternal
and fetal circulation. The organ exhibits an amazing range of
morphological variations across species (Benirschke et al., 2012).
Formation of a placenta is of great importance for
the development of the embryo and starts very early in
pregnancy. The first differentiation process gives rise to
trophoblast cells. Trophoblasts initiate implantation of the
embryo into the maternal endometrium by interaction with
decidual cells of the maternal uterus. By proliferation, invasion
and differentiation, trophoblast cells are the most important
builders of the placenta. With progression of (human) placenta
formation, two distinct populations of trophoblast cells, the
villous and the extravillous trophoblast, which exhibit distinct
functions, become evident. The expanding chorionic villi of the
placenta, which mediate materno-fetal transport of nutrients
are covered by a multinucleated layer of syncytiotrophoblast
(STB). This cell layer is maintained by proliferation and
fusion of the underlying villous cytotrophoblasts. Extravillous
trophoblasts, in contrast, invade the uterus and interact
with maternal cells. These cells are important for proper
placentation.
The process of implantation of the conceptus is species
dependent and can be either invasive as seen in humans,
most primates, dog, cat mouse, rat, or rabbit meaning that the
conceptus will break through the surface epithel of the maternal
uterus and invades the underlying stroma or can be non-invasive
(pig, sheep, cow, horse), integrating the uterine epithelium in
the placenta. The depths of invasion as well as the degree of
proximity between maternal and fetal circulation can vary largely
among species. In humans and guinea pigs, the conceptus invades
the stroma so deeply that the uterine surface epithelium is
restored over it (interstitial implantation). Other species (dog,
cat, rat), may invade the stroma only partially and project into
the uterine lumen (eccentric implantation). This can result in
a contact to other sites of the uterine lumen and additional
placental development (e.g., bidiscoid placenta in rhesusmonkey,
zonary placenta in dog and cat). While in some species the
maternal tissue remains relatively intact (dog, cat), meaning that
trophoblast cells contact maternal capillary endothelium, in other
species, trophoblast cells also invade the maternal endothelium
and ultimately bath in maternal blood (human, rabbit, rat,
mouse). These types of placentas are classified as haemochorial,
which means that all maternal tissue layers are removed and the
chorion (i.e., the trophoblast) bathes directly in maternal blood.
But even structures of murine and human placentas differ to
some extent. Whereas, the term human placenta is monochorial,
which means that one continuous trophoblast cell layer, the
STB, separates maternal and fetal blood circulation, the murine
placenta is trichorial. Moreover, in rodent placenta, but not
in human, other primate, or ruminant placentas the primitive
yolk sac, which in all species participates in nutrient exchange
between the fetal and maternal circulations before the formation
of the placenta, is incorporated into the placenta and turns
into the intraplacental yolk sac (IPYS). The IPYS is positioned
between fetal vessels and maternal blood spaces, well situated
for exchange of substances between mother and fetus. It is a
bilayered membrane, where smaller parietal or cuboidal cells
on a thick basement membrane (Reichert’s membrane) overlie
maternal blood spaces and vessels, while tall columnar cells on
the visceral or endothelial side overly the fetal vessels. Between
these layers is the sinus of Duval, which communicates with the
yolk sac cavity and the uterine lumen (Metz et al., 1976).
To ensure optimal fetal development, the placenta fulfills a
plethora of functions including gas exchange, nutrient transfer,
hormone secretion, and immunological functions. Materno-fetal
transfer of the ion Ca2+ is indispensable for proper development
including mineralization of fetal skeleton. About 30 g Ca2+ are
actively transported across the human placenta, predominantly
during the last trimester of pregnancy. As fetal serum Ca2+
concentrations are set at significant higher concentrations than
maternal serum concentrations, trans-placental Ca2+ transport
occurs against an extracellular Ca2+-concentration gradient.
Placental transfer of Ca2+ involves various proteins, including
Ca2+ channels, Ca2+-ATPases and intracellular Ca2+-binding
proteins (Calbindin-D9k). Current knowledge on placental Ca2+
transfer as well as regulation of maternal and fetal Ca2+
homeostasis have been reviewed in several recent publications
(Baczyk et al., 2011; Olausson et al., 2012; Kovacs, 2014, 2015,
2016).
Despite this active Ca2+ transfer, the placental trophoblasts
still uses Ca2+ as a second messenger to activate diverse cellular
functions such as differentiation or proliferation, or—in the case
of extravillous trophoblasts—also invasion (Baczyk et al., 2011).
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CaSR Expression and Function in
Trophoblast and Yolk Sac Cells
An involvement of CaSR in regulation of murine placental Ca2+
transfer was confirmed by heterozygous or homozygous ablation
of the CaSR gene in mice. Casr knock down reduced placental
Ca2+ transfer. CaSR disruption may, directly or indirectly,
downregulate PTHrP or influence the PTHrP effect on the
placenta (Kovacs et al., 1998). PTHrP reaches the maternal
circulation during pregnancy most likely from the placenta and
breasts, as well as possibly from the uterus and fetal tissues.
PTHrP significantly stimulates the placental Ca2+ transport via
proteins involved in transport (Kovacs et al., 1996; Strid et al.,
2002; Bond et al., 2008). A Nuf mice with an activating mutation
of CaSR exists (Hough et al., 2004), but, placental Ca2+ transport
has not been analyzed in this strain. In murine placentas, CaSR
mRNAwas detected by in situ hybridization in both types of IPYS
cells, but not in the trophoblasts. By immunohistochemistry,
using a monoclonal antibody directed against a region of the
CaSR that has been deleted in the Casr-null mice, the CaSR was
found to be expressed in both layers of the IPYS (Table 1). CaSR
was also present in the surrounding labyrinth trophoblasts of
wt placenta, but was absent in placentas obtained from Casr-
null mice. Other molecules important for materno-fetal Ca2+-
transfer, including PTHrP, PTH/PTHrP receptor, calbindin-D9k,
or Ca2+-ATPase, were also higher expressed in the IPYS of
the murine placenta compared to the trophoblasts. Overall, this
suggests that IPYS is the important route of Ca2+exchange
between mother and fetus in the mouse (Kovacs et al., 2002).
Some evidence for involvement of human CaSR in
transplacental Ca2+-transfer has been obtained recently.
Reduced expression of CaSR in placentas derived from women
suffering from gestational diabetes mellitus compared with
healthy placentas was found. This was associated with lower
Ca2+ levels measured in cord blood of infants from women
suffering from gestational diabetes mellitus supporting its role in
placental Ca2+-transfer (Papadopoulou et al., 2014). In humans,
expression of CaSR was found in both villous and extravillous
tissue of first trimester and term placentas (Table 1). In chorionic
villi, CaSR was mainly detected at the apical membrane of
the STB, which contacts maternal blood and at lower levels in
cytotrophoblast cells (Figure 3). This location would be in line
with the control of placental Ca2+movement. The CaSR was
also localized in extravillous trophoblast cells in close proximity
to maternal blood vessels (Figure 3). It was speculated that
CaSR senses maternal extracellular Ca2+ levels during the
process of placentation and participates in regulation of placental
development (Bradbury et al., 2002). Earlier, Bradbury and
coworker had demonstrated that isolated human extravillous
cytotrophoblasts expressed the full-length transcript of CaSR.
A splice variant lacking exon 3 was also found, which encoded
a truncated protein of 153 amino acids (compared with 1078
amino acids for the full length protein). Upon translation, this
CaSR splice variant, however, would not be incorporated into the
plasma membrane. The extravillous cytotrophoblasts responded
to elevation of extracellular Ca2+, and also to extracellular Mg2+
with a bi-phasic elevation of intracellular Ca2+ (Bradbury et al.,
1998).
Research Demand
CaSR modulates transplacental Ca2+ transfer, at least in
the mouse. Some evidence also exists for a role in human
transplacental Ca2+ transfer. In breast cells, CaSR is expressed in
the basolateral membrane of the lactating alveolus and regulates
PTHrP secretion. CaSR senses the availability of Ca2+ for milk
production, and stimulates production of PTHrP when the
Ca2+supply is insufficient. CaSR also impacts on a Ca2+-ATPase
(PMCA2) to stimulate Ca2+ secretion into milk when the Ca2+
supply is adequate (Kovacs, 2016). In the murine placenta, CaSR
impacts on PTHrP, but detailed information of CaSR function
in the murine or human hemochorial placentas is lacking.
Information on expression of CaSR in the epitheliochorial
placentas of other species is lacking.
CaSR can regulate proliferation, differentiation or apoptosis,
but neither in extravillous nor villous human trophoblasts
this issue has been addressed so far. Expression of CaSR
in extravillous trophoblasts suggests an important role in
placentation. In this context, not only Ca2+, but also other CaSR
ligands such as L-amino acids (Conigrave et al., 2000) may
be modulators of placental tissue development in response to
e.g., maternal Ca2+ concentration or maternal diet. Signaling
pathways targeted by CaSR in the placenta are also unknown.
A detailed understanding of the modulators of placentation is
necessary before effective interventions can be considered.
Finally, it remains to be demonstrated whether CaSR is the
only relevant Ca2+-sensing protein of the placenta. In 1989,
Juhlin and colaborators generated several monoclonal anti-
parathyroid antibodies (E11, G11, B6) by immunization of mice
with intact parathyroid cells. Two of these antibodies (G11 and
B6) interfered with the Ca2+-sensing mechanism of parathyroid
cells (Juhlin et al., 1987). When monoclonal antibody E11 was
applied in immunohistochemistry on placenta and uterus of the
pregnant rat, positively stained rat placental cells were found
at the end of pregnancy. Staining was confined exclusively to
the columnar epithelial cells lining the sinuses of Duval, i.e.,
in the IPYS. In the uterus, positive staining of the epithelium
lining the uterine lumen was obtained prior to and during
implantation (days 5–6) (Bernadotte et al., 1989). When G11
and E11 were applied on sections of human placenta, both
antibodies labeled the cytotrophoblast cells of anchoring and
floating villi as well as cytotrophoblasts in the chorionic plate.
The STB, however, was not stained. Isolated cytotrophoblast
were found to react with G11 and E11. In these cells, a
temporary increase of Ca2+i upon elevation of external Mg
2+
was observed, which was blocked by G11 antibodies. Raised
extracellular Ca2+ inhibited release of PTHrp from the cells,
and this inhibition was blocked by the G11 antibody (Hellman
et al., 1992). E11 was also used in immunoelectron microscopical
studies showing positive staining of cytotrophoblast cells of the
human placenta, and trophoblast cells lining fetal blood vessels
in the rat placenta (Bjerneroth et al., 1992). Both antibodies,
however, detected a 500 kDa protein, which is much larger
than CaSR (Juhlin et al., 1990). When the protein was then
cloned from human placenta, it was found to belong to the LDL-
receptor superfamily of glycoprotein and it was identified as
gp330 (megalin, LRP2) (Lundgren et al., 1994; Hjälm et al., 1996).
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FIGURE 3 | The cartoon depicts major components of the human placenta. Cells, which were shown to express CaSR are depicted in red (for details on
assumed function of CaSR see Table 1).
In addition to expression in human parathyroid cells, kidney
proximal tubule cells and placental cytotrophoblasts, the protein
was also detected in other reproductive tissues such as epididymal
epithelial cells andmammary epithelium. It was suggested to have
Ca2+ sensing functions (Lundgren et al., 1997). Unfortunately,
further investigations to clarify the role of this protein in Ca2+
sensing were not performed.
SUMMARY AND OUTLOOK
CaSR is expressed in many cells of male and female reproductive
organs. Due to its functional diversity, CaSR could be involved
in a variety of reproductive processes ranging from proliferation
or maturation of germ cells to implantation of the zygote,
and from placentation to transplacental transport processes.
Apart from physiologic actions, current data also suggest a
role of CaSR in diseases of reproductive organs or pregnancy.
Currently, however, we know very little about CaSRs physiologic
and pathophysiologic functions in reproduction. Exploration
of CaSR function in the context of diseases of reproduction
such as male and female infertility and early pregnancy loss,
PCOS, or gestational diabetes mellitus as well as tumors of
reproductive organs may add novel possibilities for diagnosis and
treatment.
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